This HTML5 document contains 184 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n11http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36633637
rdf:type
wikibase:Item
schema:description
2012年論文 vetenskaplig artikel vědecký článek artikull shkencor ২৪ মে ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012년 논문 scienca artikolo vitenskapelig artikkel 2012 nî lūn-bûn научни чланак videnskabelig artikel מאמר מדעי บทความทางวิทยาศาสตร์ vitskapeleg artikkel научная статья scientific article published on 24 May 2012 2012年論文 2012年论文 tudományos cikk article científic επιστημονικό άρθρο 2012年论文 vedecký článok articolo scientifico 2012年论文 artículo científico publicado en 2012 2012年論文 article scientifique artikulong pang-agham artigo científico articol științific artículu científicu espublizáu en 2012 2012年論文 artikel ilmiah naučni članak scientific article published on 24 May 2012 мақолаи илмӣ 2012年论文 artykuł naukowy наукова стаття, опублікована в травні 2012 wissenschaftlicher Artikel bài báo khoa học artigo científico научни чланак tieteellinen artikkeli article scientific научна статия სამეცნიერო სტატია 2012年論文 2012年论文 2012年の論文 artigo científico bilimsel makale مقالة علمية نشرت في 24 مايو 2012 2012年论文 wetenschappelijk artikel scientific article published on 24 May 2012 teaduslik artikkel
p:P577
wds:Q36633637-552433B2-D904-4267-B1E1-8E4D823C3E0A
wdt:P577
2012-05-24T00:00:00Z
p:P407
wds:Q36633637-AE14BF86-499A-4C8B-91FA-0F3432A6C590
wdt:P407
wd:Q1860
p:P2888
wds:Q36633637-E18BCAA2-9D7C-4EA4-BD0A-ED3F2F2A9A5A
wdt:P2888
n13:cc11358
p:P2860
wds:Q36633637-D861BBE0-78C9-42A2-9BCE-8C1AA6A34C81 wds:Q36633637-E4215933-A327-4B66-B6AA-735B3C1A6673 wds:Q36633637-E618B9BD-E3F0-4A0C-9096-BA15BCEB9846 wds:Q36633637-F8E187C6-A86C-410E-ADF7-96CE17FF93C9 wds:Q36633637-FD456822-FD05-4337-9469-252C531C6EAD wds:Q36633637-FF785451-620E-4B83-B9B6-ADEB8275DA89 wds:Q36633637-C80A4EF5-96F9-48A8-8BA9-D25C55A7BACD wds:Q36633637-C8271AB1-F4D9-44E0-944D-59F36E804DC0 wds:Q36633637-C87F3C5C-2988-423A-BD9A-4006D3571159 wds:Q36633637-C9992B43-637D-464C-846E-EF295D0BE5E7 wds:Q36633637-ADC44CCB-BA71-4E32-872B-F33E2072D837 wds:Q36633637-B3A06AF1-0081-47C7-9EC5-337ACD285259 wds:Q36633637-C0B22DC5-548F-4822-B0B9-7738EBCCE5F7 wds:Q36633637-C551EEEE-67E7-4BA9-A565-C7C7E81F5A35 wds:Q36633637-C62CEF16-B8EE-4ABD-AAD7-11B5893FA2CB wds:Q36633637-000DF552-3B54-429F-A66B-CAF6136405DF wds:Q36633637-6ACD4BA9-2EE9-47D0-8553-2D3C1E2739C0 wds:Q36633637-8EB875DD-E90D-4105-8BA2-A79087E8026E wds:Q36633637-A6D23D2F-47EF-4703-8901-C8A7007F2AA2 wds:Q36633637-AB04F464-EF9A-4EB1-8412-C92CE333E476 wds:Q36633637-57F5FEE6-0E37-436A-B9EA-346C009E9C03 wds:Q36633637-61234894-0106-41D5-9759-F0A12C64D018 wds:Q36633637-326E6817-466E-494A-8428-8DD2F240D850 wds:Q36633637-3464458F-C05D-4970-8FAA-66969F5B6B30 wds:Q36633637-385B9A0A-06A8-458E-85D3-81F33872798D wds:Q36633637-4236FEC3-2D55-45AE-AF7F-64064AF9FB2C wds:Q36633637-02573CC0-55D7-42CA-9286-3B2224CE00BC wds:Q36633637-1E369230-963C-42D8-A0CF-7688295157E1 wds:Q36633637-1F433837-8187-4AC7-BB7E-3CE1A9552A68
wdt:P2860
wd:Q48830043 wd:Q43899703 wd:Q27860596 wd:Q44636418 wd:Q46663844 wd:Q33679447 wd:Q45129340 wd:Q46479921 wd:Q43472656 wd:Q61362937 wd:Q73348279 wd:Q36093621 wd:Q46423060 wd:Q61411664 wd:Q44818063 wd:Q45335455 wd:Q34686604 wd:Q44411320 wd:Q29011237 wd:Q28264234 wd:Q46767902 wd:Q21203739 wd:Q29615602 wd:Q33919086 wd:Q46441548 wd:Q44116042 wd:Q36168292 wd:Q21195082 wd:Q46585592
p:P2093
wds:Q36633637-D3A4E616-54F6-4262-814D-E9991AEB5930 wds:Q36633637-BBE82739-A8EC-453B-AB24-631F34329CD2 wds:Q36633637-3CC2ECE1-A713-4873-8EE3-A2A7F3967936 wds:Q36633637-2070CB11-58A0-41EC-B676-CC0B1F94E994 wds:Q36633637-200AD444-C085-4498-A4DC-7EC5A3F71D9E wds:Q36633637-107FA220-00C3-4B90-8248-E237E2E1262E wds:Q36633637-05183B59-C9B3-4079-BF50-CD4DE23B180F wds:Q36633637-6E311231-3481-4A09-8073-2AF55FEB62A2 wds:Q36633637-54A7DAEF-8491-4288-A508-F07F95486851 wds:Q36633637-4956694C-6942-4B8B-A5A3-71651F506A3F wds:Q36633637-4B62966B-4BD9-44F8-9FC0-9758AF667CD5
wdt:P2093
Alexandra Heininger Olivier Martinet Michel Hasselmann Hugo Van Aken Jean François Poussel Bertrand Guidet Xavier Forceville Thierry Boulain Francois Philippart Julien Maizel Marc Feissel
rdfs:label
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study
skos:prefLabel
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study
schema:name
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study
p:P1476
wds:Q36633637-7917519C-CF93-490E-B55E-46E24034A80B
wdt:P1476
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study
p:P304
wds:Q36633637-5E6ACCFF-B5CB-4DCF-893A-E76A1C50B538
wdt:P304
R94
p:P31
wds:Q36633637-D132D7DA-E081-42EC-A413-1C9711D1756E
wdt:P31
wd:Q13442814
p:P921
wds:Q36633637-3905D265-C1C0-4E46-8A98-109D231DA1B7 wds:Q36633637-2FB29BBF-AB5F-422B-862D-DD3412B50911 wds:Q36633637-EE0DF92C-2FEC-46AB-9298-F8D46045E0CC
wdt:P921
wd:Q1642137 wd:Q181600 wd:Q183134
p:P698
wds:Q36633637-07D5A68A-C71A-4023-8B9D-E9819FDBE949
wdtn:P698
n10:22624531
wdt:P698
22624531
p:P1433
wds:Q36633637-D667BD92-6AF9-4A4F-A4C1-915B99C9E615
wdt:P1433
wd:Q5186602
p:P433
wds:Q36633637-0F0CF42C-FB37-46B9-84C8-CBFB948D65C5
p:P478
wds:Q36633637-D34BB679-69E3-4128-A8A2-5F5A9F50BECA
wdt:P433
3
wdt:P478
16
p:P356
wds:Q36633637-A791FD41-6E35-43A6-8075-17375AF44CF0
wdtn:P356
n11:CC11358
wdt:P356
10.1186/CC11358
p:P5875
wds:Q36633637-B7A104D3-9051-4759-98A6-9ACB24360388
wdt:P5875
225042788
p:P6179
wds:Q36633637-AA7D90C1-F8B6-478C-97AF-F09BEC7BAEEE
wdt:P6179
1064134819
p:P932
wds:Q36633637-5C0D34E8-A858-4FED-84B7-C9020CC9E7E9
wdt:P932
3580640